Tyme Technologies Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 1

Tyme Technologies General Information

Description

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.

Contact Information

Website
www.tymeinc.com
Formerly Known As
Tyme
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1 Pluckemin Way
  • Suite 103
  • Bedminster, NJ 07921
  • United States
+1 (212)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Former Stock Listing
TYME
Corporate Office
  • 1 Pluckemin Way
  • Suite 103
  • Bedminster, NJ 07921
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tyme Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tyme Technologies‘s full profile, request access.

Request a free trial

Tyme Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development a
Biotechnology
Bedminster, NJ
13 As of 2022

Plymouth Meeting, PA
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tyme Technologies Competitors (2)

One of Tyme Technologies’s 2 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Agenus Formerly VC-backed Lexington, MA
You’re viewing 2 of 2 competitors. Get the full list »

Tyme Technologies Patents

Tyme Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4175938-A1 Crystalline forms of metyrosine Inactive 01-Jul-2020
US-20220002227-A1 Crystalline forms of metyrosine Inactive 01-Jul-2020
WO-2022006366-A1 Crystalline forms of metyrosine Inactive 01-Jul-2020
EP-3909587-A1 Methods of treating sars-cov-2 infections Inactive 14-May-2020
US-10905698-B1 Methods of treating sars-cov-2 infections Inactive 14-May-2020 A61K31/575
To view Tyme Technologies’s complete patent history, request access »

Tyme Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tyme Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tyme Technologies‘s full profile, request access.

Request a free trial

Tyme Technologies Acquisitions (1)

Tyme Technologies’s most recent deal was a Merger/Acquisition with Tyme. The deal was made on 19-Mar-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tyme 19-Mar-2015 Merger/Acquisition Beverages
To view Tyme Technologies’s complete acquisitions history, request access »

Tyme Technologies FAQs

  • When was Tyme Technologies founded?

    Tyme Technologies was founded in 2011.

  • Where is Tyme Technologies headquartered?

    Tyme Technologies is headquartered in Bedminster, NJ.

  • What is the size of Tyme Technologies?

    Tyme Technologies has 13 total employees.

  • What industry is Tyme Technologies in?

    Tyme Technologies’s primary industry is Biotechnology.

  • Is Tyme Technologies a private or public company?

    Tyme Technologies is a Private company.

  • What is the current valuation of Tyme Technologies?

    The current valuation of Tyme Technologies is .

  • What is Tyme Technologies’s current revenue?

    The current revenue for Tyme Technologies is .

  • How much funding has Tyme Technologies raised over time?

    Tyme Technologies has raised $35M.

  • Who are Tyme Technologies’s investors?

    Eagle Pharmaceuticals, Global Emerging Markets, LDA Capital, and Tyme have invested in Tyme Technologies.

  • Who are Tyme Technologies’s competitors?

    Inovio Pharmaceuticals and Agenus are competitors of Tyme Technologies.

  • When was Tyme Technologies acquired?

    Tyme Technologies was acquired on 16-Sep-2022.

  • Who acquired Tyme Technologies?

    Tyme Technologies was acquired by Syros Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process